Eli Lilly and Company has announced it would introduce a lower-priced version of Humalog® (insulin lispro injection 100 …
Insulin
Why Do Long and Short Acting Insulin Pens Look Nearly Identical?
On the top Tresiba long-acting basal insulin, in the middle old Fiasp and on the bottom new Fiasp ultra-rapid insulin
…
8 Reasons Why Insulin is so Outrageously Expensive
This story was co-written by James Elliott and Elizabeth Pfiester. It originally appeared on T1International.
Why does …
Smart Insulin Pens For Today And The Future
When NovoPen by Novo Nordisk hit the market back in 1985, this first FDA approved insulin pen changed the way millions o…
Why is Insulin So Expensive in America?
I was stuck for many years pushing paperwork in a miserable job that I hated. Why did I stay? Because I needed insurance…
Beyond Pump Systems: The Case for Insulin Pens
Medical Innovations Must Benefit All, Not Some.
I’ve been living with Type 1 diabetes for more than 30 years, and I have…
How Close are Researchers to Developing Insulin that Doesn’t Need Refrigeration?
While many diabetes researchers are focusing on treatments and possible cures using nanotechnology, implantable devices,…
FDA Approves Admelog, First Short-Acting Insulin Copycat
The U.S. Food and Drug Administration today approved Admelog (insulin lispro injection), a short-acting insulin indicate…
Insulin Kit for Children with Diabetes Wins Dyson Design Award
For Renata Souza Luque designing an award-winning method for children with diabetes to not only administer their insulin…
FDA Approves Fiasp, Novo Nordisk’s New Fast-Acting Insulin
Today, the U.S. FDA approved Novo Nordisk’s Fiasp (insulin aspart injection) 100 Units/mL, a fast-acting mealtime insuli…